Medical Disclaimer

Not medical advice

The information published on 44 Protocol — including doses, schedules, reconstitution math, titration ladders, monitoring panels, and adverse-effect lists — is presented for educational and research-literature reference only.

It does not constitute medical advice. It does not constitute a recommendation to use, take, or administer any compound. It does not constitute a diagnosis, prescription, or treatment plan for any condition.

No clinician-patient relationship

Use of 44 Protocol does not create a doctor-patient or clinician-patient relationship between you and Stoneveil Holdings LLC or any of its operators, employees, or agents. We are not your physician.

Always consult a licensed physician

Before initiating, modifying, pausing, or discontinuing any compound, schedule, or protocol described or computed on this Service, you must consult a licensed physician who is qualified to evaluate your individual health status and to supervise the relevant clinical decisions.

This is true for FDA-approved indications and especially true for off-label, pre-clinical, and research-use-only compounds.

We are not a pharmacy and we do not sell compounds

44 Protocol is not a pharmacy. We are not affiliated with any compounding pharmacy or peptide vendor. We do not manufacture, sell, source, ship, prescribe, dispense, or recommend the purchase of any peptide or compound. We are a reference register only.

From time to time the Service may include outbound links to third-party retailers as part of an affiliate or partnership arrangement. Those links are clearly disclosed where they appear. They do not constitute an endorsement, verification, or recommendation of any product, and they do not change the fact that 44 Protocol itself is not the seller. Whether you obtain a compound, from whom, and whether it is legal to do so in your jurisdiction, is your responsibility to determine with your licensed physician and applicable law.

Regulatory status varies

Some compounds in the catalog are FDA-approved. Most are not. Several are explicitly research-use-only (RUO). The legal status of any specific compound depends on your jurisdiction and may change over time. The catalog labels current regulatory status to the best of our knowledge as of the effective date, but you must verify independently.

Risk

Peptide therapies carry risk, including risks that are not yet fully characterised in the published literature. The monitoring panels and adverse-effect lists published on this Service are not exhaustive and may not anticipate every risk relevant to your individual case.

You assume all risk associated with any clinical use of the information published here.

Emergencies

If you believe you are experiencing a medical emergency, stop using the Service immediately and call emergency services in your jurisdiction (911 in the United States). Do not use 44 Protocol as a substitute for emergency medical care.

Your acknowledgement

By creating an account or using 44 Protocol, you acknowledge that you have read, understood, and accepted this disclaimer; that you will consult a licensed physician before initiating any compound described on this Service; and that Stoneveil Holdings LLC is not liable for any clinical outcome arising from your use of the Service.